agilon health vs Quest Diagnostics
Quest Diagnostics reported revenue of $11.0 billion in fiscal 2025, 1.9 times agilon health's $5.9 billion in fiscal 2025. agilon health's revenue fell 2.1% in its latest year, and Quest Diagnostics' grew 11.8%. agilon health had an operating margin of -7.8%, against 14.1% at Quest Diagnostics. Free cash flow was −$119 million at agilon health and $1.4 billion at Quest Diagnostics.
Side by side
| agilon health | Quest Diagnostics | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $5.9B | $11.0B |
| Revenue growth | −2.1% | 11.8% |
| Revenue growth a year, last 5 years | 37.2% | 3.2% |
| Gross margin | — | 33.2% |
| Operating margin | −7.8% | 14.1% |
| Net margin | −6.6% | 9.0% |
| Free cash flow | −$119M | $1.4B |
| Free cash flow margin | −2.0% | 12.3% |
| Return on capital | — | 9.5% |
| Net debt to EBITDA | — | 2.5x |
| Dividends and buybacks | $0M | $803M |
| Change in diluted share count | 0.7% | 0.0% |
| Last close | $115.66 | $259.60 |
| P/E at the last close | — | 25.9× |
| Insider trades, last 12 months | — | sold $45.8 million |
| Piotroski F-score | 1 of 8 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
agilon healthQuest Diagnostics
Operating margin
Percent of revenue
agilon healthQuest Diagnostics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
agilon healthQuest Diagnostics
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the agilon health and Quest Diagnostics pages.